Advanced Medicine

Discovery & Development Drug Delivery

06/26/2023 | Stephanie Vine | 15 min read

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

Discovery & Development Drug Discovery

06/22/2023 | Jamie Irvine | 3 min read

Pharma experts discuss the most exciting industry breakthroughs in recent years

Manufacture Advanced Medicine

06/05/2023 | Catherine Buchere, Kathrin Teschner | 7 min read

Understanding AAV production and characterization processes – and establishing strategies for success.

Discovery & Development Drug Discovery

05/18/2023 | Jamie Irvine | 2 min read

The Lung Cancer Research Foundation has partnered with Daiichi Sankyo and AstraZeneca to offer grants for research exploring ADCs against lung cancer

Discovery & Development Drug Delivery

05/12/2023 | Jamie Irvine

Leading pharma industry experts discuss the most pertinent challenges facing cell and gene therapy

Discovery & Development Formulation

05/09/2023 | 3 min read

An insight into the research fuelling developments for universal cancer immunotherapies

Manufacture Advanced Medicine

04/27/2023 | Stephanie Vine

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Manufacture Advanced Medicine

04/25/2023 | Mark Sawicki | 4 min read

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?

Discovery & Development Drug Discovery

04/21/2023 | Stephanie Vine | 6 min read

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

Manufacture Advanced Medicine

04/12/2023 | Rob Coker | 5 min read

Oligonucleotides are a complex but promising new modality in therapeutics. Director of New Modalities at CatSci Nigel Richardson explains why.